Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Recruiting1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Benjamin VERRET, MD

Gustave Roussy, Cancer Campus, Grand Paris

Related
1 trials

Shared therapeutic areas:

Adult patients with advanced hormone receptor positive (HR+), HER2- breast cancer after at least a first line of endocrine therapy combined with CDK4/6 inhibitor in the metastatic settingMetastatic (Stage IV) Melanoma

Worked with same sponsors:

PfizerUNICANCER
Collaborated on 1 trial
Similarity Score24%

Lior Braunstein, MD

Memorial Sloan Kettering Cancer Center

Related
3 trials

Shared therapeutic areas:

Breast Cancer MetastaticBreast Cancer Stage IV
Similarity Score15%

Thomas M Campbell, MD

University of Rochester

Related
3 trials

Shared therapeutic areas:

Breast Cancer MetastaticBreast Cancer Stage IV
Similarity Score15%

Michelle Melisko, MD

University of California, San Francisco

Related
5 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score8%

Bushra Shirazi

Sindh Institute of Urology and Transplantation

Related
2 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score8%

Nicola Fusco, MD

Istituto Europeo di Oncologia

Related
2 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score8%

Vanessa M Sanvido, PhD

Hospital do Coracao

Related
2 trials

Shared therapeutic areas:

Breast Cancer Stage IV

Worked with same sponsors:

Pfizer
Similarity Score8%

Antonio Llombart-Cussac

Arnau de Vilanova Hospital, Valencia (Spain)

Related
2 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score8%

Devika Jutagir, PhD

Memorial Sloan Kettering Cancer Center

Related
4 trials

Shared therapeutic areas:

Breast Cancer Stage IV
Similarity Score8%

Antonio Llombart

MedSIR

Related
2 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06680596Phase 2PrincipalInvestigator

Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy

Breast Cancer MetastaticBreast Cancer Stage IV
Recruiting
NCT07340619Phase 2PrincipalInvestigator

Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.

Metastatic (Stage IV) Melanoma
Not Yet Recruiting

All 2 trials loaded